Corporate Headquarters

                        Abcam plc
                        Discovery Drive
                        Cambridge Biomedical Campus
                        CB2 0AX
                        F: +44 (0)1223 215 215

                        Nominated Advisors and Corporate Broker

                        J.P. Morgan Cazenove
                        25 Bank Street
                        Canary Wharf
                        London E14 5JP

                        Public Relations Advisors

                        FTI Consulting
                        200 Aldersgate
                        Aldersgate Street
                        London EC1A 4HD
                        F: +44 (0)20 3727 1007

                        Joint Corporate Broker

                        Numis Securities Limited
                        The London Stock Exchange Building,
                        10 Paternoster Square, London,
                        EC4M 7LT

                        Note on Unsolicited phone calls

                        We have been made aware of instances where our shareholders have been called regarding their shareholding by persons offering to purchase their shares. This is what is known as a ‘boiler room scam’. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports. If you receive such a call, you are advised not to get into a conversation, note the name of the person and firm contacting you and then end the call.

                        Worried about shareholder fraud? Click here for advice from the Financial Conduct Authority

                        About Abcam

                        Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

                        Read more +

                        Abcam Products

                        As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

                        Read more +

                        Investor Information

                        Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

                        Read more +

                        Abcam News

                        We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

                        Read more +